T2DM-UIP | T2DM-non-UIP | ||
---|---|---|---|
(n = 61) | (n = 53) | P | |
IPVV (mL) | 164.4 ± 68.7 | 202.9 ± 76.3 | 0.005 |
Age (years) | 72.0 ± 8.4 | 66.1 ± 7.1 | < 0.001 |
Female (%) | 17(27.9) | 15(28.3) | 0.959 |
Disease duration (months) | 12.6 ± 8.5 | 11.7 ± 9.8 | 0.699 |
Smoking history (years) | 40(65.6) | 22(41.5) | 0.01 |
BMI (kg/m^2) | 24.8 ± 2.5 | 24.5 ± 3.2 | 0.655 |
FPG (mmol/L) | 7.7 ± 3.1 | 6.5 ± 1.5 | 0.014 |
HbA1c (mmol/mol) | 57.8 ± 15.7 | 51.3 ± 10.5 | 0.015 |
Baseline C-peptide levels (ng/mL) | 3.2 ± 1.8 | 2.1 ± 0.8 | 0.033 |
fasting insulin (uU/ml) | 10.6 ± 3.3 | 24.0 ± 32.2 | 0.037 |
TG (mmol/L) | 1.4 ± 0.7 | 1.6 ± 0.8 | 0.302 |
TC (mmol/L) | 4.4 ± 1.1 | 4.6 ± 1.0 | 0.433 |
LDL-C (mmol/L) | 2.5 ± 0.9 | 2.6 ± 0.9 | 0.549 |
HDL-C (mmol/L) | 1.2 ± 0.3 | 1.2 ± 0.3 | 0.49 |
Hcy (umol/L) | 16(8–27.1) | 12(8.9–24.7) | 0.019 |
SCr (umol/L) | 103.7 ± 182.7 | 78.1 ± 24.0 | 0.338 |
SUA (umol/L) | 320.3 ± 78.4 | 341.2 ± 84.5 | 0.201 |
SUA/SCr | 4.2 ± 1.2 | 4.5 ± 1.1 | 0.127 |
Cys-C (mg/L) | 1.2 ± 0.9 | 0.9 ± 0.3 | 0.059 |
LDH (U/L) | 206.2 ± 37.7 | 182.8 ± 42.5 | 0.014 |
Use of insulin | 17(27.9) | 17(32.1) | 0.624 |